Research Article
Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data
| Parameter | Mean | RSE (%) | Description |
| Tlag (h) | 0.512 | 8.48 | Latency time | Ka (h-1) | 0.523 | 8.54 | Absorption constant | Cl/F (L/h) | 30.3 | 8.25 | Apparent clearance | βCL-CLCr | -0.204 | 43.7 | | Q/F (L/h) | 17.0 | 12.1 | Apparent clearance of distribution | V1 (L) | 17.9 | 17.6 | Apparent volume of central compartment | V2 (L) | 400 | 45.6 | Apparent volume of peripheral compartment | IIV Cl (%) | 39.8 | 16.6 | Interindividual variability of Cl | IIV Q (%) | 53.2 | 18.7 | Interindividual variability of Q | IOV Cl (%) | 38.0 | 8.53 | Interoccasion variability of Cl | IOV tlag (%) | 54.1 | 12.4 | Interoccasion variability of tlag | IOV ka (%) | 52.6 | 9.85 | Interoccasion variability of ka | Ka-Cl | -0.551 | 20.2 | Correlation between Ka-Cl | Prop (%) | 0.228 | 8.86 | Proportional error | Add (ng/mL) | 7.52 | 45.0 | Additive error | AIC | 6204 | | Akaike information criterion |
|
|